{"certainAgreement":{"piSponsorEmployee":true},"limitationsAndCaveats":{"description":"Pomalidomide and rituximab could have a synergistic effect on serum IgM levels and produce an IgM flare. The highest dose of pomalidomide in this trial was 1mg. The study was permanently closed to accrual given the safety concerns with the IgM flare."},"pointOfContact":{"email":"steven_treon@dfci.harvard.edu","organization":"Dana-Farber Cancer Institute","phone":"617-632-2681","title":"Steven P. Treon"}}